Skip to main content

Find Clinical Trials

Home
Conditions
Metastatic Breast Cancer

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Completed

Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases

NCT01004172

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Evaluation Of CanADVICE+®M-Health System To Support Breast Cancer Patients Receiving Capecitabine

NCT02580396

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations: The Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom

View Trial Details

Completed

Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer

NCT00477464

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +5 more
Locations: GSK Investigational Site Aichi, Japan

GSK Investigational Site Chiba, Japan

GSK Investigational Site Ehime, Japan

GSK Investigational Site Fukuoka, Japan

View all 15 locations

View Trial Details

Completed

Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer

NCT01837095

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations: St Luke's Cancer Institute Kansas City, Kansas, United States

Washington University School of Medicine, Division of Oncology St Louis, Missouri, United States

'Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

Weill Cornell Breast Center New York, United States

View Trial Details

Completed

Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer

NCT02361112

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Completed

Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons

NCT00627978

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations: Weill Medical College of Cornell University New York, United States

View Trial Details

Completed

Non-interventional Study With Nab-Paclitaxel (Abraxane®)

NCT01689610

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +7 more
Locations: iOMEDICO AG Freiburg im Breisgau, Baden-Wurttemberg, Germany

View Trial Details

Completed

Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy

NCT01401959

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +8 more
Locations: Florida Cancer Specialists North Fort Myers, Florida, United States

Florida Cancer Specialists South Fort Myers, Florida, United States

Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States

Florida Hospital Cancer Insitute Orlando, Florida, United States

View all 18 locations

View Trial Details

Completed

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

NCT00728949

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations: ImClone Investigational Site Scottsdale, Arizona, United States

ImClone Investigational Site Chicago, Illinois, United States

ImClone Investigational Site Westwood, Kansas, United States

ImClone Investigational Site Rochester, Minnesota, United States

View Trial Details

Completed

Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI

NCT01797120

Conditions: Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations: Marin Cancer Care Greenbrae, California, United States

Stanford University Stanford, California, United States

SwedishAmerican Regional Cancer Center Rockford, Illinois, United States

McFarland Clinic, PC Ames, Iowa, United States

View all 25 locations

View Trial Details